Cormorant Asset Management’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $35M | Hold |
|
|||||
|
2023
Q4 | $46.8M | Buy |
|
|||||
|
2023
Q3 | $2.94M | Hold |
|
|||||
|
2023
Q2 | $4.6M | Hold |
|
|||||
|
2023
Q1 | $2.77M | Hold |
|
|||||
|
2022
Q4 | $6.9M | Sell |
|
|||||
|
2022
Q3 | $6.82M | Hold |
|
|||||
|
2022
Q2 | $5.76M | Hold |
|
|||||
|
2022
Q1 | $12M | Sell |
|
|||||
|
2021
Q4 | $16.4M | Sell |
|
|||||
|
2021
Q3 | $74.8M | Buy |
|
|||||
|
2021
Q2 | $48.6M | Buy |
|
|||||
|
2021
Q1 | $65M | Hold |
|
|||||
|
2020
Q4 | $76M | Sell |
|
|||||
|
2020
Q3 | $36M | Buy |
|